Literature DB >> 31098548

Building the business case for quality improvement: a framework for evaluating return on investment.

Amar Shah1, Steven Course1.   

Abstract

There is increasing interest and belief in applying quality improvement (QI) to help solve our most complex challenges in healthcare, yet little published literature to help leaders develop a business case and evaluate return on investment from QI. This is even more pronounced in fields such as mental health and community health services. This paper presents a framework to help identify, understand and evaluate return on investment from large-scale application of QI in healthcare providers. The framework has been developed at East London NHS Foundation Trust (ELFT), a provider of predominantly mental health and community health services to a population of 1.5 million people, which has been undertaking QI at scale since 2014. This paper presents case studies and examples from ELFT to illustrate return on investment from QI at multiple levels: improving outcomes for patients and service users, improving the experience of staff, improving productivity and efficiency, avoiding costs, reducing costs and increasing revenue.

Entities:  

Keywords:  Quality improvement; business case; organisational change; quality

Year:  2018        PMID: 31098548      PMCID: PMC6502557          DOI: 10.7861/futurehosp.5-2-132

Source DB:  PubMed          Journal:  Future Healthc J        ISSN: 2514-6645


  2 in total

1.  Telling the story of complex change: an Impact Framework for the real world.

Authors:  Jo Willett; Michelle Barclay; Felix Mukoro; Grace Sweeney
Journal:  Int J Qual Health Care       Date:  2021-07-03       Impact factor: 2.038

2.  Identifying and understanding benefits associated with return-on-investment from large-scale healthcare Quality Improvement programmes: an integrative systematic literature review.

Authors:  S'thembile Thusini; Maria Milenova; Noushig Nahabedian; Barbara Grey; Tayana Soukup; Claire Henderson
Journal:  BMC Health Serv Res       Date:  2022-08-24       Impact factor: 2.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.